Literature DB >> 8985347

Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens.

A Bergqvist1, K Söderbärg, G Magnusson.   

Abstract

Infection with some virus types induces susceptibility to the cytotoxic effect of tumor necrosis factor alpha (TNF-alpha). To investigate whether expression of polyomavirus proteins has this effect on cells, the TNF-alpha sensitivity of C127 and L929 mouse cells transfected with viral DNA was analyzed. Expression of all three polyomavirus early proteins, the tumor (T) antigens, had no apparent effect. In contrast, middle T antigen by itself induced hypersensitivity to TNF-alpha. This effect was reversed by retransfection of the cells with DNA encoding small T antigen. Expression of this polypeptide also decreased the sensitivity of bovine papillomavirus type 1-transformed cells to TNF-alpha, showing that the protective function of the polyomavirus small T antigen was not strictly linked to a middle-T-antigen-induced event. Mouse and human TNF-alpha had the same effect on normal and transformed mouse cells, suggesting that this effect was mediated by TNF receptor 1. Consistent with this conclusion, all cell clones used in the experiments expressed TNF receptor 1 at similar levels, while we failed to detect TNF receptor 2. The amount of receptor on the cells was not influenced by binding of the ligand. Addition of TNF-alpha at cytotoxic concentrations to cells expressing middle T antigen by itself resulted in significant fragmentation of chromosomal DNA after only a few hours, indicating induction of apoptosis. Addition of the cytokine to these cells also leads to release of arachidonic acid, showing that phospholipase A2 was activated. However, production of arachidonic acid did not appear to significantly precede loss of cell viability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985347      PMCID: PMC191048     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor.

Authors:  L R Gooding; L W Elmore; A E Tollefson; H A Brady; W S Wold
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

2.  Association of the polyomavirus middle-T antigen with c-yes protein.

Authors:  S Kornbluth; M Sudol; H Hanafusa
Journal:  Nature       Date:  1987 Jan 8-14       Impact factor: 49.962

3.  Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production.

Authors:  D C Pallas; C Schley; M Mahoney; E Harlow; B S Schaffhausen; T M Roberts
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Phosphatidylinositol metabolism and polyoma-mediated transformation.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; L Raptis; R L Garcea; D Pallas; T M Roberts; L Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Antiviral effects of recombinant human tumor necrosis factor.

Authors:  M Ito; J A O'Malley
Journal:  Lymphokine Res       Date:  1987

6.  An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.

Authors:  S A Courtneidge; A Heber
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

7.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

8.  Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.

Authors:  J L Urban; H M Shepard; J L Rothstein; B J Sugarman; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.

Authors:  A A Creasey; M T Reynolds; W Laird
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

Authors:  G H Wong; D V Goeddel
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

View more
  8 in total

1.  Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.

Authors:  S Zhang; G Magnusson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A.

Authors:  K P Mullane; M Ratnofsky; X Culleré; B Schaffhausen
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

4.  Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation.

Authors:  E Sontag; J M Sontag; A Garcia
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

5.  Induction of p53-independent apoptosis by simian virus 40 small t antigen.

Authors:  O Gjoerup; D Zaveri; T M Roberts
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis.

Authors:  A Yen; L Placanica; S Bloom; S Varvayanis
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

7.  Regulation of membrane release in apoptosis.

Authors:  J Zhang; T A Driscoll; Y A Hannun; L M Obeid
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

Review 8.  TNF-induced signaling in apoptosis.

Authors:  P C Rath; B B Aggarwal
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.